crizotinib and Histiocytoma--Benign-Fibrous

crizotinib has been researched along with Histiocytoma--Benign-Fibrous* in 1 studies

Other Studies

1 other study(ies) available for crizotinib and Histiocytoma--Benign-Fibrous

ArticleYear
Durable response to crizotinib in metastatic angiomatoid fibrous histiocytoma with EWSR1-CREB1 fusion and ALK overexpression.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2022, Volume: 33, Issue:8

    Topics: Crizotinib; Cyclic AMP Response Element-Binding Protein; Histiocytoma, Benign Fibrous; Histiocytoma, Malignant Fibrous; Humans; Oncogene Proteins, Fusion; Receptor Protein-Tyrosine Kinases; RNA-Binding Protein EWS

2022